Literature DB >> 16734855

Prevalence of erectile dysfunction in patients with metabolic syndrome.

Tevfik Demir1, Omer Demir, Aykut Kefi, Abdurrahman Comlekci, Sena Yesil, Adil Esen.   

Abstract

AIM: We wished to investigate the relationship between metabolic syndrome and erectile dysfunction (ED).
MATERIALS AND METHODS: A total of 268 patients were included in this study. All of the patients were asked to fill in an International Index for Erectile Function (IIEF) questionnaire. The presence of metabolic syndrome was determined when any three or more of the five risk factors were present according to the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP)-III. The relationship between risk factor for metabolic syndrome and ED status was determined according to logistic regression analysis.
RESULTS: Eighty-nine patients (33%) constituted the metabolic syndrome group. IIEF-EF domain scores of patients with and without metabolic syndrome were 17.7 +/- 7.9 and 21.7 +/- 7.5, respectively (P < 0.001). Seventy-four percent of patients with metabolic syndrome and 50% of patients without metabolic syndrome had ED (P < 0.001; odds ratio 2.9; 95% CI 1.7-5.0). Erectile function domain scores significantly decreased as the number of metabolic risk factors increased (P < 0.001). Patients with the risk factor of fasting blood glucose (FBG), waist circumference (WC), or hypertension (HT) had lower erectile function domain scores than the patients with other metabolic risk factors. Logistic regression analysis revealed that FBG and WC were the most important criteria for ED.
CONCLUSIONS: Metabolic syndrome seems to be a potential risk factor for ED. We recommend patients with metabolic syndrome should be questioned about ED, and WC measurement might take part in the evaluation of ED.

Entities:  

Mesh:

Year:  2006        PMID: 16734855     DOI: 10.1111/j.1442-2042.2006.01310.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  14 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 2.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

3.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

4.  The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males.

Authors:  M-D Shi; J-K Chao; M-C Ma; S-K Chiang; I-C Chao
Journal:  Int J Impot Res       Date:  2014-07-31       Impact factor: 2.896

5.  Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects.

Authors:  A Gatti; E Mandosi; M Fallarino; A Radicioni; E Morini; F Maiani; V Trischitta; A Lenzi; S Morano
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

6.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 7.  Metabolic syndrome and risk for ED: a meta-analysis.

Authors:  L H Liu; T Zhang; Y R Zhang; T S Liu; H B Zhang; F Z Chen; S H He; A Y Wei
Journal:  Int J Impot Res       Date:  2014-03-06       Impact factor: 2.896

8.  Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms.

Authors:  J C Trussell; Allen R Kunselman; Richard S Legro
Journal:  Fertil Steril       Date:  2008-12-04       Impact factor: 7.329

9.  The influence of metabolic profile of obese men on the severity of erectile dysfunction: are metabolically healthy obese individuals protected?

Authors:  Adriana Moura; Inês Tomada; Nuno Tomada
Journal:  Turk J Urol       Date:  2018-11

10.  Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model.

Authors:  Amr Abdelhamed; Shin-Ichi Hisasue; Masato Shirai; Kazuhito Matsushita; Yoshiaki Wakumoto; Akira Tsujimura; Taiji Tsukamoto; Shigeo Horie
Journal:  Res Rep Urol       Date:  2015-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.